Akero Therapeutics (AKRO) had the highest return between May 1, 2022 and November 30, 2022 by a mid-cap US stock, returning 342.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | 5/1/2022 - 11/30/2022 | 342.86% |
Rhythm Pharmaceuticals (RYTM) | 5/1/2022 - 11/30/2022 | 331.77% |
Nuvalent (NUVL) | 5/1/2022 - 11/30/2022 | 218.3% |
Verona Pharma PLC ADR (VRNA) | 5/1/2022 - 11/30/2022 | 212.35% |
TransMedics (TMDX) | 5/1/2022 - 11/30/2022 | 193.78% |
Immunovant (IMVT) | 5/1/2022 - 11/30/2022 | 183.15% |
Modine Manufacturing (MOD) | 5/1/2022 - 11/30/2022 | 168.65% |
Biohaven Pharmaceutical (BHVN) | 5/1/2022 - 11/30/2022 | 163.67% |
Impinj (PI) | 5/1/2022 - 11/30/2022 | 159.78% |
Axsome Therapeutics (AXSM) | 5/1/2022 - 11/30/2022 | 132.37% |
F&G Annuities & Life (FG) | 5/1/2022 - 11/30/2022 | 129.9% |
ELF Beauty (ELF) | 5/1/2022 - 11/30/2022 | 125.25% |
New Oriental Education & Technology (EDU) | 5/1/2022 - 11/30/2022 | 124.53% |
Catalyst Pharmaceuticals (CPRX) | 5/1/2022 - 11/30/2022 | 120.08% |
Celsius (CELH) | 5/1/2022 - 11/30/2022 | 114.12% |
Enphase Energy (ENPH) | 5/1/2022 - 11/30/2022 | 101.16% |
Griffon (GFF) | 5/1/2022 - 11/30/2022 | 93.13% |
Vaxcyte (PCVX) | 5/1/2022 - 11/30/2022 | 90.57% |
Arcellx (ACLX) | 5/1/2022 - 11/30/2022 | 86.01% |
TAL Education (TAL) | 5/1/2022 - 11/30/2022 | 82.01% |
Hafnia (HAFN) | 5/1/2022 - 11/30/2022 | 81.71% |
ADMA Biologics (ADMA) | 5/1/2022 - 11/30/2022 | 81.52% |
Wingstop (WING) | 5/1/2022 - 11/30/2022 | 80.48% |
Calix (CALX) | 5/1/2022 - 11/30/2022 | 78.79% |
Vista Oil Gas ADR (VIST) | 5/1/2022 - 11/30/2022 | 72.37% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
